Procaps Group SA (PROC)
2.95
+0.37
(+14.34%)
USD |
NASDAQ |
May 17, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Procaps Group Free Cash Flow (Quarterly): 39.71M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 39.71M |
| June 30, 2023 | 12.57M |
| March 31, 2023 | -1.756M |
| December 31, 2022 | -16.47M |
| September 30, 2022 | -1.67M |
| June 30, 2022 | -1.64M |
| March 31, 2022 | 2.31M |
| December 31, 2021 | -21.34M |
| Date | Value |
|---|---|
| September 30, 2021 | 27.37M |
| June 30, 2021 | 0.185M |
| March 31, 2021 | 6.556M |
| December 31, 2020 | 34.74M |
| September 30, 2020 | -2.709M |
| June 30, 2020 | 5.21M |
| March 31, 2020 | 15.76M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-21.34M
Minimum
Dec 2021
39.71M
Maximum
Sep 2023
6.590M
Average
2.31M
Median
Mar 2022
Free Cash Flow (Quarterly) Benchmarks
| Alvotech | -77.62M |
| Moolec Science SA | -3.897M |
| Perspective Therapeutics Inc | 4.776M |
| Electromed Inc | 1.222M |
| Xtant Medical Holdings Inc | -6.528M |